Abstract
Locally applied clotrimazole (Canesten) proved to be effective in the treatment of dermatophytosis. It was also effective but to a lesser degree in cases of Onychomycosis mostly due toCandida albicans. The drug was well tolerated.
Similar content being viewed by others
References
Marget, W. & Adam. 1969. ‘First experience with the broad-spectrum antimycotic Bay b 5097’. Wein. Clin. Wacher., 27, 1235–1238.
Freis, A. 1971. ‘Results of clinical trials with the antimycotic Bay b 5097 in dermatomycosis’. Proceedings of the 5th. Congress of the International Society for Human & Animal Mycology, Paris, 311–312.
Fredriksson, T. 1972. ‘Topical treatment with Bay b 5097, a new broad spectrum antimycotic agent’. Br. J. Derm., 86, 628–630.
El Zawahry, M., M. K. Moawad & M. Soliman. 1973. ‘Topical treatment of dermatomycosis with canesten cream, a new antimycotic compound’. Mykosen, 16, 363–365.
Abdel A'al & M. K. Moawad. 1973. ‘Clinical Experience with Canesten cream (Bay b 5097) against dermatophytes in Egypt’. Mykosen, 16, 369–371.
Mahgoub, E. S. 1972. ‘Laboratory and clinical experience with clotrimazole’. Sabouraudia, 10, 212–216.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mahgoub, E.S. Clinical trial with clotrimazole cream (Bay b 5097) in dermatophytosis and onychomycosis. Mycopathologia 56, 149–152 (1975). https://doi.org/10.1007/BF02093313
Issue Date:
DOI: https://doi.org/10.1007/BF02093313